Technology resource planning in radiation oncology: application of a needs-based analytic framework to radiosurgery planning in Ontario.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3500481)

Published in J Oncol Pract on July 24, 2012

Authors

Jeffrey N Greenspoon1, Daria O'Reilly, James R Wright, Anthony Whitton, Jonathan Sussman, Stephen Birch

Author Affiliations

1: McMaster University, Ontario, Canada. jeffrey.greenspoon@jcc.hhsc.ca

Associated clinical trials:

Radiation Therapy in Treating Patients With Prostate Cancer | NCT01434290

Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis | NCT00922974

Robotic Compared to Fixed Gantry Radiosurgery for Brain Metastases (TRICK) | NCT01353573

Articles cited by this

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet (2004) 7.78

A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys (2007) 5.07

The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol (2009) 1.96

Intracranial metastases from systemic cancer. Adv Neurol (1978) 1.92

Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol (2007) 1.51

To each according to need: a community-based approach to allocating health care resources. CMAJ (1993) 1.07

A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. Int J Radiat Oncol Biol Phys (1997) 1.06

Therapeutic advances in the treatment of brain metastases. Clin Adv Hematol Oncol (2007) 0.97

Surgical brain metastases: management and outcome related to prognostic indexes: a critical review of a ten-year series. ISRN Surg (2011) 0.83

Radiosurgery scope of practice in Canada: a report of the Canadian association of radiation oncology (CARO) radiosurgery advisory committee. Radiother Oncol (2010) 0.80

TomoTherapy, Gamma Knife, and CyberKnife Therapies for Patients with Tumours of the Lung, Central Nervous System, or Intra-abdomen: A Systematic Review of Clinical Effectiveness and Cost-Effectiveness. CADTH Technol Overv (2010) 0.80

Articles by these authors

(truncated to the top 100)

Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol (2011) 5.67

Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol (2006) 4.32

Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. J Clin Oncol (2011) 3.05

"Interaction" and research utilisation in health policies and programs: does it work? Health Policy (2005) 2.33

Access as a policy-relevant concept in low- and middle-income countries. Health Econ Policy Law (2009) 2.13

The effect of different methods of remuneration on the behaviour of primary care dentists. Cochrane Database Syst Rev (2013) 2.07

Exploring inequalities in access to and use of maternal health services in South Africa. BMC Health Serv Res (2012) 2.01

Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources. Soc Sci Med (2003) 2.01

Underrecognition of pathologist contributions to articles published in a major multidisciplinary medical journal. Am J Clin Pathol (2012) 1.96

The importance of reporting patient recruitment details in phase III trials. J Clin Oncol (2006) 1.92

The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β. Exp Physiol (2012) 1.85

Calculating utility decrements associated with an adverse event: marginal Tobit and CLAD coefficients should be used with caution. Med Decis Making (2011) 1.67

Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada. J Vasc Surg (2008) 1.53

Recruitment strategies for minority participation: challenges and cost lessons from the POWER interview. Ethn Dis (2005) 1.52

Incremental cost-effectiveness ratios (ICERs): the silence of the lambda. Soc Sci Med (2005) 1.47

Symptom burden and performance status in a population-based cohort of ambulatory cancer patients. Cancer (2010) 1.47

Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice. Xenotransplantation (2014) 1.47

Patient preferences for oropharyngeal cancer treatment de-escalation. Head Neck (2012) 1.45

On the impossibility of trigger point-acupoint equivalence: a commentary on Peter Dorsher's analysis. J Altern Complement Med (2008) 1.45

Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction. Cancer (2005) 1.43

The association of the palliative performance scale and hazard of death in an ambulatory cancer population. J Palliat Med (2012) 1.41

The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trials. J Am Med Inform Assoc (2011) 1.38

A systematic review of studies evaluating diffusion and dissemination of selected cancer control interventions. Health Psychol (2005) 1.36

Who you know, where you live: social capital, neighbourhood and health. Soc Sci Med (2004) 1.33

A review of the reliability of traditional East Asian medicine diagnoses. J Altern Complement Med (2009) 1.33

Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? Value Health (2010) 1.32

Clinician-patient communication: a systematic review. Support Care Cancer (2009) 1.27

Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin (2007) 1.23

Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (2011) 1.20

A review of the cost of cardiovascular disease. Can J Cardiol (2009) 1.20

Histological analysis of achilles tendons in an overuse rat model. J Orthop Res (2008) 1.19

Inclusion of drugs in provincial drug benefit programs: Should "reasonable decisions" lead to uncontrolled growth in expenditures? CMAJ (2003) 1.18

The Diabetes Continuity of Care Scale: the development and initial evaluation of a questionnaire that measures continuity of care from the patient perspective. Health Soc Care Community (2004) 1.16

An applied simulation model for estimating the supply of and requirements for registered nurses based on population health needs. Policy Polit Nurs Pract (2009) 1.15

Clinical experience using hypofractionated radiation schedules in breast cancer. Semin Radiat Oncol (2008) 1.11

Eliminating the shortage of registered nurses in Canada: an exercise in applied needs-based planning. Health Policy (2011) 1.10

NICE methodological guidelines and decision making in the National Health Service in England and Wales. Pharmacoeconomics (2003) 1.09

Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement. Qual Life Res (2008) 1.08

Planning for what? Challenging the assumptions of health human resources planning. Health Policy (2009) 1.07

Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13. J Clin Oncol (2006) 1.07

Unemployment and health: contextual-level influences on the production of health in populations. Soc Sci Med (2002) 1.07

Resource use and costs of end-of-Life/palliative care: Ontario adult cancer patients dying during 2002 and 2003. J Palliat Care (2011) 1.05

Do high symptom scores trigger clinical actions? An audit after implementing electronic symptom screening. J Oncol Pract (2012) 1.01

A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial. Blood (2013) 1.01

Towards improving the co-ordination of supportive cancer care services in the community. Health Policy (2004) 1.00

Who is responsible? The role of family physicians in the provision of supportive cancer care. J Oncol Pract (2009) 0.99

A framework for costing diagnostic methods in oral health care: an application comparing a new imaging technology with the conventional approach for maxillary canines with eruption disturbances. Community Dent Oral Epidemiol (2012) 0.99

Effects of study design and trends for EVAR versus OSR. Vasc Health Risk Manag (2008) 0.97

Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada. Clinicoecon Outcomes Res (2012) 0.96

Equity in the use of antiretroviral treatment in the public health care system in urban South Africa. Health Policy (2010) 0.96

Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. Clinicoecon Outcomes Res (2011) 0.95

The effects of nursing turnover on continuity of care in isolated First Nation communities. Can J Nurs Res (2005) 0.95

Safety of tissue expander/implant versus autologous abdominal tissue breast reconstruction in postmastectomy breast cancer patients: a systematic review and meta-analysis. Plast Reconstr Surg (2014) 0.94

Intra-arterial thrombolysis vs. standard treatment or intravenous thrombolysis in adults with acute ischemic stroke: a systematic review and meta-analysis. Int J Stroke (2013) 0.94

Factors Associated with End-of-Life Health Service Use in Patients Dying of Cancer. Healthc Policy (2010) 0.93

Individual and regional determinants of mammography uptake. Can J Public Health (2004) 0.93

Multidisciplinary health care professionals' perceptions of the use and utility of a symptom assessment system for oncology patients. J Oncol Pract (2011) 0.92

Inequalities in neighbourhood socioeconomic characteristics: potential evidence-base for neighbourhood health planning. Int J Health Geogr (2005) 0.92

Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. Clinicoecon Outcomes Res (2012) 0.92

Enabling medication management through health information technology (Health IT). Evid Rep Technol Assess (Full Rep) (2011) 0.92

A review of methods used in long-term cost-effectiveness models of diabetes mellitus treatment. Pharmacoeconomics (2010) 0.92

Are family physician visits and continuity of care associated with acute care use at end-of-life? A population-based cohort study of homecare cancer patients. Palliat Med (2013) 0.91

Three-year outcomes of a Canadian multicenter study of accelerated partial breast irradiation using conformal radiation therapy. Int J Radiat Oncol Biol Phys (2010) 0.91

First experience with a novel robotic remote catheter system: Amigo™ mapping trial. J Interv Card Electrophysiol (2013) 0.90

Management of the low-grade abnormal Pap smear: What are women's preferences? J Fam Pract (2002) 0.90

What constitutes a "clinical trial"?: a survey of oncology professionals. Trials (2008) 0.89

Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstet Gynecol (2010) 0.89

Association of phosphorylated epidermal growth factor receptor with survival in patients with locally advanced non-small cell lung cancer treated with radiotherapy. J Thorac Oncol (2008) 0.89

Optimizing the mix of basic dental services for Southern Thai schoolchildren based on resource consumption, service needs and parental preference. Community Dent Oral Epidemiol (2009) 0.89

A cost-effectiveness model comparing endovascular repair to open surgical repair of abdominal aortic aneurysms in Canada. Value Health (2008) 0.88

E-health interventions as complex interventions: improving the quality of methods of assessment. AMIA Annu Symp Proc (2006) 0.88

Human beta cells are exceedingly resistant to streptozotocin in vivo. Endocrinology (2002) 0.88

A review of health utilities across conditions common in paediatric and adult populations. Health Qual Life Outcomes (2010) 0.88

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada. Cost Eff Resour Alloc (2010) 0.88

Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational study. Eur J Health Econ (2009) 0.88

Opioid prescription after pain assessment: a population-based cohort of elderly patients with cancer. J Clin Oncol (2012) 0.88

Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India. Health Policy (2005) 0.87

Factors affecting the implementation of complex and evolving technologies: multiple case study of intensity-modulated radiation therapy (IMRT) in Ontario, Canada. BMC Health Serv Res (2011) 0.87

Gender differences in experiences of ART services in South Africa: a mixed methods study. Trop Med Int Health (2012) 0.87

Core domains for a person-focused outcome measurement system in cancer (PROMS-Cancer Core) for routine care: a scoping review and Canadian Delphi Consensus. Value Health (2013) 0.87

Do patient-reported symptoms predict emergency department visits in cancer patients? A population-based analysis. Ann Emerg Med (2013) 0.86

Investigating the reliability of Japanese toyohari meridian therapy diagnosis. J Altern Complement Med (2009) 0.86

Geographic disparity in premature mortality in Ontario, 1992-1996. Int J Health Geogr (2003) 0.86

Unequal access to ART: exploratory results from rural and urban case studies of ART use. Sex Transm Infect (2012) 0.86

Insulin expression in the brain and pituitary cells of tilapia (Oreochromis niloticus). Brain Res (2007) 0.86

Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada. J Am Coll Radiol (2009) 0.86

Coordination of palliative cancer care in the community: "unfinished business". Support Care Cancer (2009) 0.86

Prevention versus cure: measuring parental preferences for sealants and fillings as treatments for childhood caries in Southern Thailand. Health Policy (2007) 0.85

Understanding the results of meta-analyses in the treatment of head and neck squamous cell cancer. Hematol Oncol Clin North Am (2008) 0.84

Modeling the longitudinal transitions of performance status in cancer outpatients: time to discuss palliative care. J Pain Symptom Manage (2012) 0.84

Home care evolution in alberta: how have palliative clients fared? Healthc Policy (2007) 0.83

Provider incentives and access to dental care: evaluating NHS reforms in England. Soc Sci Med (2012) 0.83

The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes. Health Econ (2002) 0.83

The public's viewpoint on the right to hastened death in Alberta, Canada: findings from a population survey study. Health Soc Care Community (2012) 0.83

Variation in healthcare services for specialist genetic testing and implications for planning genetic services: the example of inherited retinal dystrophy in the English NHS. J Community Genet (2015) 0.83

Identifying changes in scores on the EORTC-QLQ-C30 representing a change in patients' supportive care needs. Qual Life Res (2014) 0.83

Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation. Liver Transpl (2014) 0.82

C-Kit-positive metastatic malignant pigmented clear-cell epithelioid tumor arising from the kidney in a child without tuberous sclerosis. Ann Diagn Pathol (2005) 0.82

Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura. J Popul Ther Clin Pharmacol (2012) 0.82

Universal or targeted screening for fetal alcohol exposure: a cost-effectiveness analysis. J Stud Alcohol Drugs (2008) 0.82